TradeOrgs
  • Stocks
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← All stocks

🇺🇸APUS

Apimeds Pharmaceuticals US, Inc. Common Stock

NYSE
$0.90
▼ $0.42 (-31.8%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 02 Jul 2026
H $30.00L $0.78-94.6%
$30$24.16$18.31$12.47$6.62$0.78$0.9
RSI (14)
Intraday · 15-minSell-20RSI 51DowntrendMACD Bullishfor day-trading context — not advice

Technical signal

Sell-30
RSI (14)34
oversold 30overbought 70
Trend
Downtrend
MACD
Bullish
Bollinger
Within bands
vs 20-day
below
vs 50-day
below
vs 200-day
below
Support
$0.78
Resistance
$1.55
  • Price is below its 50-day average (medium-term weakness).

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

Signal backtest · 2025-09-29 → 2026-07-02

Strategy return
-93.9%
Buy & hold
-95.3%
Trades
9
Win rate
11%

$100,000.00 invested would be worth $6,138.06 (-93.9%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About Apimeds Pharmaceuticals US, Inc.· Drug Manufacturers - Specialty & Generic

source: yahoo

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Matawan, United States
www.mindwavedao.com ↗

Fundamentals· Energy

demo data

Live data was unavailable (the free feed can be rate-limited or blocked by region/host), so sample figures are shown. Set FINNHUB_API_KEY for a reliable fallback.

Market cap
$104.41B
P/E
38.9
P/B
7.4
EPS
$1.28
Div yield
2.4%
Profit margin
24.7%
ROE
18.9%
Debt / Equity
0.03
Beta
1.20
52-week range
$34.83 – $62.19
52-week low · $34.830% of rangehigh · $62.19

Recent news

News sentiment:▲ Positive2↑ · 0↓ · 3–
  • APUS reports quarterly results; revenue and margins in focus— Neutral
    Market Wire · 03 Jul 2026
  • Analysts revise price targets on APUS after earnings— Neutral
    Bourse Daily · 03 Jul 2026
  • APUS board approves dividend and capex plan▲ Positive
    FinNews · 02 Jul 2026
  • APUS gains as sector momentum builds▲ Positive
    The Ledger · 01 Jul 2026
  • What APUS's latest filing tells investors

Fundamental data is informational only — not investment advice.

— Neutral
Market Wire · 30 Jun 2026

Sentiment is a keyword-based read of the headline — a rough signal, not advice.